medigraphic.com
ISSN 1726-6718 (Electronic)
Revista Cubana de Anestesiología y Reanimación

2015, Number 2

<< Back Next >>

Revista Cubana de Anestesiología y Reanimación 2015; 14 (2)

Perioperative cardiovascular complications associated to the metabolic syndrome during the laparoscopic colecistectomy

Rodríguez BT, Echevarría HAT, Arpa GÁ, García PJL

Language: Spanish
References: 25
Page: 81-91
PDF size: 200.34 Kb.


ABSTRACT

Introduction: metabolic syndrome carriers face up the anesthetic surgical challenges in particular conditions, which have been insufficiently analyzed in the revised medical literature.
Objective: to identify the association between the metabolic syndrome and the appearance of perioperative cardiovascular complications during the laparoscopic colecistectomy.
Method: sample selection was carried out in a systematic way in the "Dr. Luis Díaz Soto” from May 2011 to May 2013 and it included 114 patients between 30 to 65 years old divided into three groups: Group I: composed by 38 metabolic syndrome carriers; Group II: composed by 38 obese patients and Group III: 38 hypertensive patients (without other criteria of metabolic syndrome). All groups underwent laparoscopic colecistectomy with endothracheal general anesthesia. Main variables analyzed in this study were: systolic, mean and diastolic arterial pressure, heart rate and electrocardiographic tracing.
Results: there was the tendency to perioperative hypertension and complications such us: sinusal tachycardia, the ST's depression, hypotension and cardiac rhythm disorders, particularly in the group I (p‹0, 05).
Conclusions: metabolic syndrome and isolated criteria of it (obesity and hypertension), contribute to the appearance of perioperative cardiovascular complications during the laparoscopic colecistectomy.


REFERENCES

  1. Nilson S. Research contributions of Eskil Kylin. Sven Med. 2001;5(1):15-28.

  2. Kajimoto K, Kasai T, Miyauchi K. Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery. Circ J. 2008;72(1):1481-6.

  3. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation and Treatment of High Cholesterol in Adults Human (Adult Treatment Panel III). JAMA. 2001;285:2486-97.

  4. Puig NR, Graziola E. Síndrome Metabólico, un nuevo factor de riesgo en anestesia. Rev Col Anestesiol. 2008 Nov;66(5):101-6.

  5. Opie L. Metabolic Syndrome. Circul. 2007;115(1):32-5.

  6. Bagry HS, Raghavendran S, Carli F. Metabolic Syndrome and Insulin Resistance. Perioperative Considerations. Anesthesiol. 2008;108(3):506-23.

  7. Dávila Cabo de Vila E, Gómez Brito C, Álvarez Bárzaga M, Saínz Cabrera H, Molina Lois RM. Anestesiología Clínica. 2da. ed. La Habana: ECIMED; 2006. pp. 67-82.

  8. Chiche JD, Hamoir E, Joris J, Jacquet N, Lamy M. CO2-pneumoperitoneum induces a transient alteration of splachnic haemodynamics. Anesthesiol. 1995;32(6):126.

  9. Alberti KG, Eckel RH, Grundy SM. Harmonizing the Metabolic Syndrome. Circul. 2009;120(4):1640-5.

  10. Arpa Gámez A. Primer Taller Nacional de Consenso sobre Síndrome Metabólico en las Fuerzas Armadas Revolucionarias. Rev Cub Med Milit. 2009;38(3):101‐3.

  11. Sierra P, Galcerán JM, Sabaté S, Martínez-Amenós A, Castaño J, Gil A. Documento de consenso sobre hipertensión arterial y anestesia de las Sociedades Catalanas de Anestesiología e Hipertensión Arterial. Hipertens riesgo vasc. 2009;26(5): En línea. [Consultado: agosto 9, 2012]. Disponible en: http://www.elsevier.es/hipertension.com

  12. World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013. En línea. [Consultado: Noviembre 12, 2013]. Disponible en: http://jama.jamanetwork.com/article.aspx?articleid=193387

  13. Pomares Estrada J, Palomino Romero R, Gómez Alegría CJ, Gómez Camargo D. Síndrome Metabólico y anestesia. Rev Cienc Biomed. 2010;1(1):64-70.

  14. García Gutiérrez A, Pardo Gómez G. Cirugía. La Habana: ECIMED; 2007. pp. 25-46.

  15. Rodríguez Bonet T, Rivas Cartaya JR, Vasallo Comendeiro VJ, Ávalos Martín JA, Ponce Reines L. Comportamiento cardiovascular perioperatorio en pacientes portadores de Síndrome Metabólico. Rev Cubana Anest Reanim. 2009;8(3):19-21.

  16. Cordero A, Alegría E, León M. Prevalencia de síndrome metabólico. Rev Esp Cardiol. 2005;5(2):11-5.

  17. Sánchez-Chaparro MA, Calvo-Bonacho E, González-Quintela A, Fernández- Labandera C, Fernández-Meseguer J. Occupation-related differences in the prevalence of metabolic syndrome. Diabetes Car. 2008;11(4):22-9.

  18. Labrada Despaigne A. Anestesia en cirugía de mínimo acceso. La Habana: Ecimed; 2010. pp. 78-89.

  19. Reaven GM. Role of Insulin Resistance in human disease. Diabetes. 1988;37:1595-1607.

  20. Phillip D. Levin MB, Weissman C. La obesidad, el síndrome metabólico y el paciente quirúrgico. Anesthesiol Clin. 2009;27(1):705-19.

  21. Jiménez Salazar A. Síndrome Metabólico. Consideraciones perioperatorias. Congreso Virtual Mexicano de Anestesiología. 2011. En línea. [Consultado: Septiembre 15, 2012]. Disponible en: http://www.entornomedico.org/salud/saludyenfermedades/alfaomega/sindromemet abolico.html

  22. Pomares Estrada J, Palomino Romero R, Gómez Alegría CJ, Gómez Camargo D. Síndrome metabólico y complicaciones perioperatorias durante cirugías programadas con anestesia general. Rev Col Anestesiol. 2010;40(2):106-12.

  23. Robinson K, Kruger P, Prins J, Venkatesh B. The metabolic syndrome in critically ill patients. Best Practice & Research Clinical Endocrinology & Metabolism. 2011;25(6):835-45.

  24. Guías de Práctica Clínica de la Sociedad Española de Cardiología. Rev Esp Cardiol. 2011;64(12):1090-5.

  25. Landechoa MF, ColinaI l, Huerta A, Fortun A, Zalba G, Beloquia O. Relación entre las fases precoces de la enfermedad renal y el síndrome metabólico. Rev Esp Cardiol. 2011;64(5):373-78.




2020     |     www.medigraphic.com